7-HOPE Alliance Responds to Misinformation in Dr. Robert Redfields Recent Op-Ed on 7-Hydroxymitragynine (7-OH) in The Hill
LOS ANGELES, CA - July 1, 2025 ( NEWMEDIAWIRE ) - 7-HOPE Alliance ('7-HOPE'), a nonprofit public education and advocacy group dedicated to responsible access to 7-hydroxymitragynine (7-OH), today issued the following letter from Scientific Advisor Dr. Michele Ross in response to former CDC Director Dr. Robert Redfield's recent opinion article published in The Hill.
Dr. Redfield's op-ed unfoundedly equated 7-OH with synthetic opioids, alleged it poses 'legal morphine-level' risks, and called for immediate enforcement action by the FDA and HHS. While his concern for public safety is genuine, it is also clear that Dr. Redfield was misinformed, likely by commercial actors with a vested interest in removing 7-OH from the market.
The following letter, written by Dr. Michele Ross and originally submitted as a Letter to the Editor with no response from the publication, directly addresses the scientific, regulatory, and policy inaccuracies in the op-ed.
'As a neuroscientist who has spent nearly two decades researching addiction and working with chronic pain patients, I share Dr. Redfield's concern about emerging drug trends. But his recent warning about 7-hydroxymitragynine, or 7-OH, paints an inaccurate and potentially harmful picture of a compound that many Americans are using to stay off far more dangerous substances.
Most concerning is the claim that 7-OH is a 'synthetic opioid.' That label is scientifically inaccurate. 7-OH is a naturally occurring compound found in the kratom plant and is also produced in significant quantities inside the human body after consuming kratom leaf. When product manufacturers produce 7-OH outside the body, they are not creating a novel or lab-invented drug. They are mimicking the body's own metabolic process using heat and oxygen, a method no different from how other botanical extracts are refined or stabilized for dietary supplements. To call this synthetic is not only misleading, it falsely associates 7-OH with fentanyl-class opioids and risks misinforming both lawmakers and the public.
Published studies show that 7-OH acts as a partial agonist at opioid receptors, unlike fentanyl, a full opioid agonist. 7-OH has a ceiling effect on euphoria which makes it more similar to the opioid use disorder treatment buprenorphine than fentanyl. Unlike traditional opioids, it does not activate the beta-arrestin 2 pathway strongly associated with respiration depression, overdose, and death. Multiple rodent studies have attempted to find a lethal dose for 7-OH and failed – that alone separates it from the synthetic opioids devastating our communities.
Dr. Redfield suggests that 7-OH poses an 'unregulated pharmaceutical threat,' but this ignores the rigorous safety practices already in place among responsible manufacturers. 7-HOPE supports strict milligram-based serving limits and accurate labeling standards, not unlike those already applied to THC and CBD in regulated markets.
Dr. Redfield also references an FDA clinical trial on natural kratom leaf to suggest 7-OH products represent a 'bait and switch.' But this misrepresents the research. That study evaluated natural kratom leaf in experienced users and found no serious adverse effects. What it also revealed is that kratom and its active metabolites, including 7-OH, show low abuse potential and may offer therapeutic benefits. Rather than contradict the utility of 7-OH, this research supports continued exploration of its properties, especially as a harm reduction tool.
Further, the suggestion that federal agencies must act immediately to issue 'import alerts' and 'classify 7-OH as an unapproved drug' is premature and reckless. Research on 7-OH is ongoing, and early findings show promise. HHS has already rejected scheduling kratom and its components once, citing the risk of immediate harm to users if access is cut off. That decision still holds today. We do not ban nicotine or even alcohol because they carry risks. We regulate them. The same approach should be applied here.
What Dr. Redfield's op-ed leaves out entirely is the human impact of a ban on 7-OH. Millions rely on 7-OH to manage pain, reduce alcohol use, or avoid relapse from other deadly synthetics. These are not hypothetical users. I have heard from consumers, veterans, and parents who credit this compound with helping them get their lives back. When people are desperate to avoid fentanyl or oxycodone but have few options, removing one of the few effective, low-toxicity alternatives is not harm reduction, it's cruelty.
Yes, 7-OH should be researched further and regulated, but as we know from repeated history,bans or broad mischaracterizations will not make people safer. They will push individuals back toward illicit markets and high-risk alternatives. If we are serious about harm reduction, we must let science, not stigma, lead the way.
Respectfully Submitted,
Dr. Michele Ross, PhD, MBA
Scientific Advisor, 7-HOPE Alliance
Author of Kratom is Medicine
7-HOPE urges lawmakers, regulators, and the media to engage with the science and lived experiences of the people who use 7-OH safely every day. We remain committed to supporting ongoing research, promoting responsible regulation, and ensuring this compound remains accessible to those who rely on it for pain relief, recovery, and stability.
For more information or to get involved, visit www.7hopealliance.org.
About 7-HOPE Alliance
7-HOPE Alliance (7-Hydroxy Outreach for Public Education) is a nonprofit organization (501(c)(3) pending) dedicated to advancing public education, user support, and policy advocacy around 7-hydroxymitragynine (7-OH), a naturally occurring alkaloid in the kratom plant. Through a foundation of science, storytelling, and community, 7-HOPE empowers individuals, healthcare professionals, and policymakers with accurate, balanced information on 7-OH and its role in harm reduction, natural wellness, and safe, legal access to alternatives. The organization's mission centers on four pillars: science, education, advocacy, and user support. By confronting misinformation, promoting responsible use, and providing uplifting real-life testimonials, 7-HOPE aims to ensure 7-OH remains available to the many individuals who find it to be a safe and effective alternative to dangerous painkillers and illegal drugs. For more information or to get involved, visit www.7hopealliance.org
Media Contact
[email protected]
View the original release on www.newmediawire.com
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Politico
32 minutes ago
- Politico
The CDC shooting aftermath
Driving the Day GUNMAN HITS THE CDC — CDC employees across all of the agency's campuses will be teleworking today, agency leadership told employees, according to a partial recording of a staff call obtained by POLITICO, after a gunman shot multiple rounds into four buildings on the agency's main campus in Atlanta on Friday. The agency is also offering administrative leave for employees who had to shelter in place. The campus saw some facility damage, including broken locks and doors, as law enforcement worked to clear and secure the area, CDC officials said on the call. Media outlets have reported that the gunman believed the Covid-19 vaccine had made him sick, citing law enforcement. A police officer was killed while responding to the incident, though no CDC staff were harmed. The agency is conducting a 'full security assessment,' agency Director Susan Monarez said on the call. 'There was a lot that went right, there was a lot that we want to make sure that we put in place so that when you do return, that everyone can feel safe and supported,' Monarez said. The backlash: Dr. Elizabeth Soda, an infectious disease doctor with the CDC's Center for Emerging and Zoonotic Infectious Diseases, called for Health Secretary Robert F. Kennedy Jr. to resign on Sunday. 'I am enraged at Robert F. Kennedy Jr.,' said Soda, noting she was speaking in her 'own private capacity.' 'As health secretary, his lies are costing people their lives. His dangerous rhetoric is making Americans sicker as scientific decision-making is destroyed.' Former U.S. Surgeon General Jerome Adams also criticized Kennedy's response, calling it 'tepid' and too slow. 'How you respond to a crisis defines a leader, and quite frankly, Secretary Kennedy has failed in his first major test in this regard,' Adams told CBS's Margaret Brennan on 'Face the Nation.' Kennedy addressed the incident in a post on social media platform X on Saturday. 'We are actively supporting CDC staff on the ground and across the agency. Public health workers show up every day with purpose — even in moments of grief and uncertainty,' he wrote. He also addressed agency staff in an email sent to CDC employees Saturday. An HHS spokesperson did not respond to a request for comment. Background: The Georgia Bureau of Investigation said 30-year-old Patrick Joseph White, of Kennesaw, Georgia, shot at the agency complex. 'He very deeply believed that vaccines had hurt him, and that they were hurting other people,' one of White's neighbors, Nancy Hoalst, told The New York Times on Saturday. DeKalb County police officer David Rose was shot and killed while responding to the attack. He was 33, had two children, and his wife was pregnant with a third. Monarez noted on the call that the agency is working to set up a donation for Rose's family. Key context: The shooting comes amid an already tumultuous time for CDC staff. Hundreds of agency employees received termination notices in April, but some were sporadically rehired. The Trump administration has also proposed slashing the agency's budget by roughly half. Kennedy has repeatedly raised concerns over the Covid vaccine's safety. Since he began leading HHS in February, the CDC has stopped recommending the vaccine for healthy pregnant people and narrowed the recommendations for healthy children. Kennedy said earlier this week that HHS would halt $500 million in funding for mRNA research, the technology used to create the first Covid vaccines, citing safety concerns. Many public health experts pushed back on that decision. WELCOME TO MONDAY PULSE. We're closely watching for the second MAHA report this week. Any intel on timing or contents? Send your tips, scoops and feedback to khooper@ and sgardner@ and follow along @kelhoops and @sophie_gardnerj. Industry Intel NEW PLAN FOR INDIRECT COSTS — Academia has a counteroffer in the standoff between the Trump administration and universities over grant funding, POLITICO's Erin Schumaker reports. The federal government has long provided grantees with funding for administrative and facilities costs on top of research awards. But now, allies of President Donald Trump accuse the schools of using the payments as slush funds to pursue progressive causes like diversity, equity and inclusion. The universities deny misusing those funds, but to placate Trump, they're proposing the establishment of a more transparent model for recouping overhead costs. Currently, those fees are negotiated separately with each institution and can vary widely. At stake is more than $4 billion in funding. Losing that money would slow the search for breakthroughs in health and science and enable foreign rivals to catch up, the scientific community says. A federal district court judge blocked the administration's plan to cap the fees at 15 percent in March, although the administration has appealed. Charting a new path: 'It's been made extremely clear to us from day one by members of Congress that if we don't do something, somebody else will,' Kelvin Droegemeier, a professor at the University of Illinois at Urbana-Champaign who's spearheading the effort on behalf of a coalition of universities and research institutes, told POLITICO. 'They said continuing forward with the current model is not in the cards. We took it to mean we could help be a part of that change or wait for it to happen,' said Droegemeier, who led the White House Office of Science and Technology Policy during Trump's first term. The group proposes a Financial Accountability in Research, or FAIR, plan, which would consist of a detailed accounting of indirect project costs and a shorter, simpler fixed percentage of a project's budget for research organizations to recoup facilities and administrative expenses. The model is designed to show the costs of conducting research so the government and lawmakers can choose what to fund. What's next: Senate Appropriations Chair Susan Collins (R-Maine), who has protested the administration's cap because it would hurt universities in her state, floated the new model to NIH Director Jay Bhattacharya at a budget hearing in June, calling it 'far fairer' than Trump's flat rate and saying she believed it would 'increase accountability.' Talks are expected to ramp up when Congress returns from recess next month. AROUND THE AGENCIES GUESS WHO'S BACK — The FDA's top vaccine regulator, who was pushed out roughly two weeks ago under pressure from the White House, has been reinstated, POLITICO's David Lim reports. After Commissioner Marty Makary requested the return of Dr. Vinay Prasad to his job regulating biologics and vaccines, the White House decided the agency could bring him back after reviewing Prasad's past remarks highlighted by far-right provocateur Laura Loomer last month, according to a person familiar with the decision and granted anonymity to discuss the decision. 'At the FDA's request, Dr. Vinay Prasad is resuming leadership of the Center for Biologics Evaluation and Research,' HHS spokesperson Andrew Nixon said. HHS declined to answer additional questions about Prasad's reinstatement. Why it matters: The return of Prasad marks a personnel victory for HHS Secretary Robert F. Kennedy Jr. and Makary, who opposed his dismissal. In the days after Prasad's ouster, Makary told reporters he encouraged Prasad to reconsider his exit from government. Loomer immediately slammed the decision to rehire Prasad on social media platform X, describing him as a progressive and referring to his past remarks criticizing President Donald Trump. 'In the coming weeks, I will be ramping up my exposes of officials within HHS and FDA so the American people can see more of the pay for play rot themselves and how rabid Trump haters continue to be hired in the Trump administration,' Loomer posted Saturday. 'There are several Senate Confirmation hearings coming up and I have multiple oppo books ready for distribution!' Sarepta Therapeutics: It's unclear what Prasad's return will mean for Sarepta Therapeutics, which sparred with the FDA center that regulates its Duchenne muscular dystrophy treatment, Elevidys, in the days before he was removed from the job last month. Industry Intel THE IMPACT OF KENNEDY'S mRNA MOVE — Messenger RNA technology, and its potential in cancer treatment and prevention, has excited scientists for years. Now, following HHS Secretary Robert F. Kennedy Jr.'s decision to yank half a billion dollars in federal funding for mRNA vaccine projects, researchers and drugmakers worry that potential will be curtailed, POLITICO's Lauren Gardner reports. Key context: The rapid development and deployment of mRNA vaccines during the pandemic stoked enthusiasm for the technology's potential to revolutionize cancer treatment. The much faster manufacturing process and the mRNA platform's ability to instruct the immune system to attack problem proteins make it possible to custom-tailor therapies to fight a person's unique tumor. Dozens of treatments are being studied or already in the pipeline. But scientists and industry executives say Kennedy's discouragement of mRNA vaccines for respiratory diseases could dampen investors' enthusiasm for U.S. companies pursuing drug candidates for cancers and rare genetic diseases that have few therapeutic options. And they fear those firms and researchers might decide to move overseas to countries hungry for their expertise — including places like China that could limit Americans' access to treatments developed within their borders. 'If there was a treatment out there for pancreatic cancer but we couldn't get access to it, how would that make you feel if you had a loved one with pancreatic cancer?' said Kate Broderick, chief innovation officer at Maravai LifeSciences, which makes components for drugs and therapies. 'And that is a genuine reality of these cancellations.' An HHS spokesperson called the industry's assessment of potential fallout from Kennedy's mRNA decisions 'false,' adding that other uses of the technology weren't affected by Tuesday's announcement. WHAT WE'RE READING The Wall Street Journal's Liz Essley Whyte reports on how Robert F. Kennedy Jr. is trying to bring MAHA to Alaska. The Washington Post's Sabrina Malhi reports on growing anti-sunscreen sentiment on social media that's worrying dermatologists.
Yahoo
2 hours ago
- Yahoo
This Popular Potato Dish Could Raise Your Risk of Diabetes, Study Finds
Key Points A new study from Harvard T.H. Chan School of Public Health found that eating french fries three times a week or more is associated with a 20% increased risk of developing type 2 diabetes. Other preparations of potato did not yield the same degree of risk, indicating that it's the cooking method that's the primary culprit. Nutritional guidelines and a dietitian emphasize that potatoes can still provide valuable nutrition, including fiber, potassium, and vitamin you love them baked, mashed, roasted, grilled, or stuffed, potatoes are popular all across America — and the world. But if you love your spuds in fry form, you might want to pause before firing up the deep fryer or placing that next fast-food fry order, because researchers at Harvard T.H. Chan School of Public Health just uncovered some potential health implications from this popular dish. The new study, published this week in The British Medical Journal, found that eating french fries three times a week was associated with a 20% increased risk of developing type 2 diabetes when compared to eating them less than once a week. This is a valuable insight considering that about 1.2 million Americans are diagnosed with diabetes every year, according to the American Diabetes Association. The Harvard team analyzed data from four decades of 205,107 adults in the United States who didn't have diabetes, cardiovascular disease, or cancer when the study began. The takeaway? The risk for developing type 2 diabetes wasn't the potato's fault on its own. Instead, it came down to how this humble ingredient was prepared, with deep-fried potatoes yielding the worst results. Is it still okay to include potatoes in your diet? Potatoes are considered a vegetable and can be included in a healthy eating plan, according to the United States Department of Agriculture's (USDA) and Department of Health and Human Services' (HHS) 2020–2025 Dietary Guidelines for Americans. 'Potatoes are a staple in many cultural diets across the globe and can absolutely be considered a 'healthy' addition to the diet,' says registered dietitian and certified personal trainer Elizabeth Shaw, MS, RDN, CPT, an author and nutrition communications strategist. Potatoes are naturally fat-free and sodium-free, in addition to containing fiber, protein, and other key vitamins and minerals. For reference, one medium cooked potato with the skin on contains 118 calories, 0.1 grams of fat, 27 grams of carbohydrates, 2.5 grams of dietary fiber, and 2.5 grams of protein. It also provides 515 milligrams of potassium and is a source of vitamin C. Can the way you cook potatoes really change how they affect your body? According to researchers, yes. This study found no significant diabetes risk associated with potato preparations such as baked, boiled, and mashed tubers or even potato chips. The only culprit? French fries. Related: Scientists Say This AI-Created Diet Could Help Reduce Your Risk of Dementia French fries are typically deep-fried in oil, heavily salted, and in some cases made with added flours, sugars, or preservatives. Take McDonald's famous fries, for example. In addition to potatoes and vegetable oil, they include beef flavoring, dextrose (a simple sugar), sodium acid pyrophosphate (an additive), and salt. One large order packs in 480 calories, 23 grams of fat, and 400 milligrams of sodium. What is the most nutritious way to cook a potato? To start, keeping the skin on potatoes for serving is an excellent choice because this is where you'll find the most fiber. 'Increasing dietary fiber has been linked to improved health outcomes, including better blood sugar control, weight management, and more,' explains Shaw. She adds that the cooking method matters too, saying, 'It's best to consider the cooking method if they're a daily part of your diet, opting for boiled, baked, air-fried, or roasted over deep-fried options.' Related: This Nut May Help Lower Cholesterol and Boost Heart Health, According to a New Study So what should a fry lover do? Shaw recommends making homemade fries and cooking them in an air fryer. 'Slicing them into steak-size fries with a spritz of olive oil and salt yields that same restaurant-quality texture and taste without the fat and calories of a traditional french fry,' she notes. Mashed potato or baked potato fans can also make a few smart swaps if desired. Instead of opting for a pat of butter or using full-fat sour cream and cheese, try mixing in Greek yogurt or light sour cream for that same creamy taste with less saturated fat. How much is too much potato? 'A medium potato, or about 5 ounces, is the standard serving size… Think about the size of a small fist,' advises Shaw. How often you enjoy potatoes will depend on your individual nutritional needs and health goals. 'Personally, I recommend variety in my clients' diets, encouraging them to alternate between russets, sweet, and red potatoes to get their potato fix in while providing their body with a variety of nutrients,' she suggests. Related: Eating Sugar? Fine. Drinking It? Not So Much If you enjoy potatoes daily, that's okay too. 'It really depends on how you're enjoying them (like baked over fried) and alongside what other nutrient-dense foods.' Shaw recommends pairing potatoes with healthy fats and protein to help support balanced blood sugar levels. What it boils down to is that there's no need to shun potatoes from your kitchen. Just pay attention to preparation methods, limiting deep-fried french fries and opting for air-fried, boiled, baked, roasted, or mashed potatoes when possible. And as always, if you're concerned about whether or not potatoes are a good addition to your diet — and especially if you're concerned about diabetes — it's best to talk with a health professional who can ensure your nutrition meets your personal needs. Read the original article on Food & Wine
New York Post
2 hours ago
- New York Post
Buttigieg says Dems should follow Trump's ‘pro-family' promises — including expanded coverage for IVF treatment
Advertisement Former transportation secretary Pete Buttigieg told 'Pod Save America' on Sunday that it would be a good idea for Democrats to adopt the Trump campaign's promise to expand coverage for in vitro fertilization (IVF) treatments. 'Do you think Democrats should run on Trump's promise from the campaign that, you know, insurance companies should be required to cover IVF and fertility treatments?' co-host Jon Favreau asked. 'I think it's good policy,' Buttigieg answered. 'I mean, if we're really serious about being pro-family, then we need to make sure that we support that. And that means making sure whether it's a system of direct government support or whether it's ensuring that that's part of what you can get from private healthcare.' He added, 'By the way, you know, I think that the right has been weird about it, but I don't think we should scoff at those who are interested in making sure that we encourage more people to be able to start families and have more kids if they want to, especially if the reason they're not doing it is artificial issues around cost or access to care.' Advertisement 4 Buttigieg said that the expansion of IVF is a good policy that is 'pro-family.' Pod Save America / YouTube 4 Lab staff prepare small petri dishes, each holding several 1-7 day old embryos, for cells to be extracted from each embryo to test for viability at the Aspire Houston Fertility Institute in vitro fertilization lab Feb. 27, 2024, in Houston. AP Favreau claimed—citing a critical Washington Post report—that President Donald Trump failed to keep his campaign promise regarding IVF treatments for women during his second term. The headline read, 'White House has no plan to mandate IVF care, despite campaign pledge.' White House spokesperson Abigail Jackson told the Washington Post in response to its report that the president's work to expand IVF access was ongoing. Advertisement 'President Trump pledged to expand access to fertility treatments for Americans who are struggling to start families,' Jackson said in a statement. 'The Administration is committed like none before to using its authorities to deliver on this pledge.' 4 President Donald Trump speaks at an event to mark National Purple Heart Day in the East Room of the White House, Thursday, Aug. 7, 2025, in Washington. AP In February, Trump signed an executive order aiming to expand access to IVF and other fertility treatments through the reduction of out-of-pocket costs. The order directed the Domestic Policy Council to find ways to make IVF and other fertility treatments more affordable. Fox News Digital reached out to the DNC for comment. Advertisement Since the 2024 election, Buttigieg has criticized his party's approach to reaching voters, going so far as to mock its obsession with diversity. 4 Joe Biden speaks alongside Transportation Secretary Pete Buttigieg (L) during a briefing on Hurricane Helene response and recovery efforts, in the Roosevelt Room of the White House on October 1, 2024 in Washington, DC. AFP via Getty Images 'What do we mean when we talk about diversity? Is it caring for people's different experiences and making sure no one is mistreated because of them, which I will always fight for? 'Or is it making people sit through a training that looks like something out of 'Portlandia,' which I have also experienced,' Buttigieg said at a forum in February. 'And it is how Trump Republicans are made,' Buttigieg added.
